The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ dated 12.04.2010 "On circulation of medicines", decided to abolish the stateregistration and exclusion from the state register of medicinal products for the medical use of the medicinal product (registration certificate No. N015141 / 01-2003 dated 11.08.2009 issued by Lilly France, France):
Humatrop® (trade name of the medicinal product)
Somatropin (international non-proprietary or grouping or chemical name)
lyophilizate for the preparation of solution for injection, 6 mg, 12 mg (dosage form, dosage)
Lilly France, France 2 rue de colonel Lilly, 67640 Fegersheim, France (name and address of the location of the manufacturer of the medicinal product)
on the basis of a filing by an authorized legal entity of the IP JSC "Eli Lilly East SA" applications for the abolition of state registration of a medicinal product.